Endocyte

📍 West Lafayette, United States🗓 Founded 1996👥 16 employees💰 Last funded May 2012
Pharmaceutical Manufacturing🌐 endocyte.com
Website LinkedIn
Endocyte is a biopharmaceutical company and leader in developing targeted therapies for the personalized treatment of cancer. The companys drug conjugation technology targets therapeutics and companion imaging agents specifically to the site of diseased cells. Endocytes lead program is a prostate specific membrane antigen (PSMA)-targeted radioligand therapy, 177Lu-PSMA-617, entering phase 3 for metastatic castration resistant prostate cancer (mCRPC). Endocyte is also advancing its adaptor-controlled CAR T-cell therapy into the clinic, where it will be studied in osteosarcoma.
2
Total investors
0
Early stage
0
Mid stage
1
Late stage
1996
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Endocyte?
Endocyte has 2 investors on record on gritt.io and 1 late-stage investors.
When did Endocyte last raise funding?
The most recent investment in Endocyte recorded on gritt.io was in May 2012.
When was Endocyte founded?
Endocyte was founded in 1996.
What industry is Endocyte in?
Endocyte operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Endocyte based?
Endocyte is headquartered in West Lafayette, United States.